FIELD: medicine, pharmacy. SUBSTANCE: invention relates to paroxetin hydrochloride anhydrate no containing bound propane-2-ol as some new forms (A, B, C and D), methods of their preparing, new intermediate compounds that are used for preparing anhydrate, namely paroxetin hydrochloride solvate, that is distinct from propane-2-ol solvate, and to a method of its preparing also. Paroxetin hydrochloride anhydrate no containing propane-2-ol in form of A, B, C, D is used for treatment of patients with alcoholism, anxiety, depression and other diseases. EFFECT: improved method of preparing, enhanced effectiveness of compounds. 13 cl, 21 ex, 16 dwg
| Title |
Year |
Author |
Number |
| METHOD OF SYNTHESIS OF 4-(4'-FLUOROPHENYL)-3-HYDROXYMETHYL-PIPERIDINES AND METHOD OF SYNTHESIS OF 4-(4'-FLUOROPHENYL)-3-(3',4'-METHYLENEDIHYDROXYPHENOXYMETHYL)-PIPERIDINE |
1994 |
- Sidnej Ehdvard Kehllender
|
RU2141477C1 |
| METHOD FOR STEREOSPECIFIC HYDROLYSIS OF PIPERIDINEDIONE DERIVATIVES |
1993 |
- Alan Dehvid Kurzons[Gb]
- Loson Uill'Jam Pauehll[Gb]
- Alan Martin Ki[Gb]
|
RU2108393C1 |
| HETEROCYCLIC COMPOUND OR ITS TAUTOMERIC FORM AND/OR PHARMACEUTICALLY ACCEPTABLE SALT AND/OR PHARMACEUTICALLY ACCEPTABLE SOLVATE, PHARMACEUTICAL COMPOSITION DECREASING BLOOD GLUCOSE LEVEL, METHOD OF TREATMENT AND/OR PROPHYLAXIS OF HYPOGLYCEMIC PATIENTS |
1993 |
- Dehvid Khej
- Dzhon Tomas Sajm
|
RU2134686C1 |
| ORAL LIQUID PHARMACEUTICAL COMPOSITION CONTAINING COMPLEX OF PAROXITINE AND AMBERLITE IRP-88 AND METHOD OF TREATMENT USING THIS COMPOSITION |
1995 |
- Grehkhehm Stehnli Leonard
- Dehvid Kuper
|
RU2136281C1 |
| METHOD OF SYNTHESIS OF BENZOPYRANE COMPOUNDS, INTERMEDIATE COMPOUNDS AND METHODS OF THEIR SYNTHESIS |
1993 |
- Grekhem Dzhonson[Gb]
- Nejl Smit[Gb]
- Richard Grekhem Dzhin[Gb]
- Inderdzhit Singkh Mehnn[Gb]
- Vehns Novak[Us]
|
RU2094428C1 |
| 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDEN]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE) |
2003 |
|
RU2284994C2 |
| PAROXETIN TABLETS AND METHOD OF THEIR MAKING |
1994 |
- Ram Dutta Patak
- Dehvid Dzhordzh Douti
|
RU2146141C1 |
| METHOD OF TREATMENT OF STATE WHERE 5HT-LIKE AGONIST, DERIVATIVE OF TETRAHYDROCARBAZOLE IS REQUIRED, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY OF AGONIST OF 5HT-LIKE RECEPTORS |
1992 |
- Frehnsis Dehvid King
- Larami Mehri Gehster
- Al'Berto Dzhulio Kaumann
- Rodni Kristofer Jang
|
RU2137474C1 |
| METHOD OF PREPARING AND/OR PURIFYING CLAVULANIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALTS OR ESTERS THEREOF CLAVULANIC ACID SALT WITH AMINO ACID |
1993 |
- Majkl Allen Kuk[Gb]
- Robert Bennett Uilkins[Gb]
|
RU2105768C1 |
| (E)-3-[2-N-BUTYL-1-{(4-CARBOXYPHENYL)-METHYL}-1H-IMIDAZOLE-5- -YL]-2-(2-THIENYL)-METHYL-2-PROPENOIC ACID METHANESULFONATE, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1992 |
- Richard Makkallok Kinen
- Dzhozef Vajnshtok
|
RU2124513C1 |
